Available Now
MARK-B™ COVID-19 Antigen Test
Simple . Accurate . Fast .
The MARK-B™ COVID-19 Ag test is a electrochemical sandwich immunoassay that is used with the MARK-B™ 1 analyzer intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens.
34mm
34mm
*The MARK-B™ 1 analyzer(MB-100) and the MARK-B™ COVID-19 Ag are CE marked.
Benefits : COVID-19 antigen test
Deliver lab-quality results in 10 mins.
Test results in 10 minutes
Fast diagnosis with results in 10 minutes in various locations such as physicians' offices, urgent care clinics and other POC locations.
Turn-around Time
Sensitivity 94.4%
specificity 100.0%
The clinical performance of MARK-B™ COVID-19 Ag was established with a study using NPS specimens, which have been previously characterized and were supplied by a biorepository in the United States. In the clinical performance, seventy-two (72) samples were measured, resulting in a sensitivity of 94.4% (34/36) and a specificity of 100.0% (36/36).
Enable the physician to verify infection quickly, begin proper treatment and to initiate isolation precautions helping prevent further spread of infection.
Accuracy
Limit of Detection
1
50
2.4 x 10 TCID /mL
Detect a positive result against the low concentration sample without amplification before any symptom onset.
*The MARK-B™ COVID-19 Ag test cartridge. It's disposable.
Specification
-
Direct sample types include: Nasopharyngeal swabs
-
Simple operation via visual touchscreen
-
Assay kit contains all necessary components for testing to include: 25 test cartridges, swabs for sample collection, reagent solution kits
-
Actionable results in 10 minutes or less
Benefits : MARK-B™ 1 analyzer
Every infectious disease test needs quick answers. That’s why you need MARK-B™ 1 analyzer; a high-performance immunoassay analyzer that provides accurate results in minutes, not hours.
-
Easy to learn and use only minimal training requirements
-
Small footprint saves you bench space
-
Can be used in any healthcare setting
-
Large visual touchscreen displays results
-
Eliminating transcription errors and the need for printing
-
No need for calibration or maintenance
-
Facilitates effective patient management
*The MARK-B™ 1 analyzer(MB-100) is CE marked.
